Acerca de

 

the prize

The Maximon Longevity Prize for Translational Research awards outstanding breakthrough research in the field of longevity that can be translated for clinical or non-clinical applications and has the potential to substantially increase health span or life span of humans.

The award focuses on research that already has a proof of concept in pre-clinical lab studies to have a significant impact on the health optimization or longevity. 

Untitled-1-01.png

the pledge

Gold winners achievement trophy on a yellow background.jpg

Maximon is on a mission to extend the health span and to allow people to be fit, healthy and happy until high-age.

We are accelerating longevity research by giving exceptional researchers the resources they need to expand their work and invest in new products and services geared to a longevity-society.

Maximon pledges 50 000 CHF for the winner and commits to attracting more donors and sponsors to further improve the award.

The prize recipient will also receive additional benefits from sponsors such as:

  • Personalized longevity program sponsored by Biolytica at the value of 20 000 CHF

  • One-year subscription for science-based longevity supplements supplied by AVEA at the value of 5 000 CHF

jury

 
foto_19_edited.png

Dr. Dr. Elisabeth Roider

Partner & Chief Scientific and Medical Officer at Maximon

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Sebastien Thuault

Chief Editor of Nature Aging

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

James Raaff

Co-Founder and Chief Program Officer at Biolytica

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Prof. Brian Kennedy

Professor Departments of Biochemistry and Physiology at National University of Singapore

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Prof. Dr. Evelyne Yehudit Bischof, MD, MPH

Associate Professor at Shanghai University of Medicine&Health Sciences

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Sophie Chabloz

Co-Founder and CPO at AVEA

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Prof. Dr. Collin Y. Ewald

Assistant Professor at ETH Zurich

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Prof. Joao Pedro de Magalhaes

Professor, University of Liverpool

linked+linkedin+logo+social+icon-1320191
Twitter.png
 
 

timeline

Screenshot 2022-02-11 at 12.37.14.png

1st of March 

2022

10th of September 

2022

29th of September

2022

25th of September

 2022

Screenshot 2022-02-11 at 12.36.02.png

Longevity prize launch.

Applications are open

Application window is closed

End of Evaluation

phase

Award Ceremony at the LIC Gala Dinner

 

application

We've welcomed applications from all academic/non-profit researchers, inventors, scientists, students or startup founders who either published breakthrough research, hold the patent or are in very advanced stages of research.

Application window has closed on September 10th.

foto_010.jpg
 

donate now

Contact us and find out more how to support the Maximon Longevity Prize

 

sponsors

Avea_Logo_Black_edited_edited_edited.png
vertica_logo_600 px_Монтажная область 1.png

partners

Longevity.Technology_Logo.png
LifespanIO_Logo_2021 (2)_edited.png
 

team

foto_19_edited.png

Dr. Tobias Reichmuth

Founding Partner

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Dr. Dr. Elisabeth Roider

Partner & Chief Scientific and Medical Officer

linked+linkedin+logo+social+icon-1320191
Twitter.png
foto_19_edited.png

Alexandra Ezhkova

Venture Head of Events

linked+linkedin+logo+social+icon-1320191
Twitter.png